|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61P 5/00 | (2006.01) |
| (11) | Number of the document | 2890397 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13760180.3 |
| Date of filing the European patent application | 2013-08-28 | |
| (97) | Date of publication of the European application | 2015-07-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/US2013/056976 |
| Date | 2013-08-28 |
| (87) | Number | WO 2014/036076 |
| Date | 2014-03-06 |
| (30) | Number | Date | Country code |
| 201261695949 P | 2012-08-31 | US | |
| 201313842906 | 2013-03-15 | US |
| (72) |
MA, Xinghang, US
XIANG, Jun, US
NIU, Jianjie, US
|
| (73) |
Bayer HealthCare LLC,
100 Bayer Boulevard, Whippany, NJ 07981-0915,
US
|
| (74) |
Jelena GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anti-prolaktino receptoriaus antikūno kompozicijos |
| ANTI-PROLACTIN RECEPTOR ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 13 | 289.00 EUR |
| 2026-08-28 |